Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
about
Meta-analysis of risk factors for Parkinson's disease dementiaSex and Gender Differences in Central Nervous System-Related DisordersA systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective studyBehavioral effects of levodopa.COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progProgression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.The psychosis spectrum in Parkinson disease.Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations.Treatment of Sleep Dysfunction in Parkinson's Disease.Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson's disease: a resting-state fMRI study.Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease.The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study.Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.Risk factors for visual hallucinations in patients with Parkinson's disease.Fatigue is associated with the onset of hallucinations in patients with Parkinson's disease: A 3-year prospective study.
P2860
Q26743404-68165A4D-3ADB-43A1-BD06-EEB5078C0BBFQ26744569-E99D4071-CA32-4D3A-8CD5-21E5AC3F6935Q30240991-8787FEE8-8901-448C-AFFA-BE9535D76902Q30249553-1CABC1FE-FECC-49E5-805F-4919B846FA5CQ33810051-4C7681EB-B88F-4007-BBCA-308B06BF3B96Q34452922-538B8242-2E83-4741-84C0-BF298BB8E92CQ36616565-24DC31A3-E42A-40C3-99AE-7B3E4C581C7FQ36655627-208CC6A0-1B44-4C00-8ADE-0D1D6B7972B6Q38258699-A7503DEC-B26D-497B-92FB-5A7F3234A405Q38768169-4DDE9D4D-0E18-4383-A6BF-BADB27F38D45Q38896237-C40B0FA4-D8EA-4084-B402-8035D5357C4BQ39032421-8E2C3862-E6D3-4507-B606-0AC78DDA1516Q39342961-9D1EB04C-987B-417A-8928-F7BD790E72BDQ40521399-B2C873D9-31C8-42E4-9ECB-BEE6242C3676Q40626246-93BA9113-B36F-4915-9669-69C61D299FBDQ47591952-0E92E138-A9A7-414C-B554-1F261F1E3AE5Q47794742-9B846D6C-DB5E-4892-94A5-78F8A0D5CD6CQ48095437-2CB2179F-9F8E-40A9-B848-693B36F5758EQ50072359-BC697AE6-C066-4AA0-8220-B1FD19A8CE64
P2860
Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Risk factors for hallucination ...... arge prospective cohort study.
@en
Risk factors for hallucination ...... arge prospective cohort study.
@nl
type
label
Risk factors for hallucination ...... arge prospective cohort study.
@en
Risk factors for hallucination ...... arge prospective cohort study.
@nl
prefLabel
Risk factors for hallucination ...... arge prospective cohort study.
@en
Risk factors for hallucination ...... arge prospective cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Risk factors for hallucination ...... large prospective cohort study
@en
P2093
Hein Putter
Jacobus J van Hilten
Kangdi Zhu
P2860
P304
P356
10.1002/MDS.25389
P407
P577
2013-03-20T00:00:00Z